The Role of B Vitamins in Gut Health and Parkinson’s Disease

by Ella

Recent research from Nagoya University has identified a significant link between gut microbiota and Parkinson’s disease (PD), revealing a deficiency in gut bacteria responsible for synthesizing essential B vitamins—specifically B2 (riboflavin) and B7 (biotin)—among PD patients. This deficiency may compromise the intestinal barrier, leading to inflammation in the brain, a hallmark of PD. The study suggests that supplementing B vitamins could potentially alleviate symptoms and slow disease progression in PD patients.

Key Points:

Gut Microbiota and B Vitamins:

Gut microbiota play a critical role in synthesizing B vitamins like riboflavin and biotin. These vitamins are essential for maintaining the integrity of the intestinal barrier, which prevents toxins from entering the bloodstream.


Impact on Parkinson’s Disease:

Researchers observed a reduction in bacterial genes responsible for B vitamin synthesis in PD patients. This deficiency may contribute to a weakened intestinal barrier, allowing toxins to enter the bloodstream and cause inflammation in the brain, exacerbating PD symptoms.


Metanalysis and Findings:

The study conducted metanalysis of stool samples from PD patients across multiple countries using shotgun sequencing. It identified decreased levels of riboflavin and biotin synthesizing bacteria in PD patients, along with reduced levels of short-chain fatty acids (SCFAs) and polyamines, which maintain intestinal barrier integrity.


Potential Therapeutic Avenue:

B vitamins such as riboflavin and biotin have anti-inflammatory properties that could counteract neuroinflammation in PD. Supplementation with these vitamins may therefore be a promising therapeutic approach to alleviate symptoms and slow disease progression.


Future Directions:

The study underscores the importance of understanding the complex interactions between gut microbiota, metabolic pathways, and neurodegenerative diseases like PD. Future research may focus on personalized treatments based on individual microbiome profiles to optimize therapeutic outcomes.

Clinical Implications:

The findings suggest potential strategies for identifying PD patients with specific microbiota deficiencies through gut microbiota analysis or fecal metabolite analysis. Targeted supplementation with riboflavin and biotin could potentially mitigate intestinal permeability and neuroinflammation associated with PD.


The study highlights the critical role of gut microbiota and B vitamins in the pathogenesis of Parkinson’s disease. By addressing deficiencies in riboflavin and biotin synthesis, clinicians may open new avenues for managing PD symptoms and potentially delaying disease progression. Further research into personalized treatment strategies based on microbiome analysis holds promise for improving outcomes in PD patients.



Wellfoodrecipes is a professional gourmet portal, the main columns include gourmet recipes, healthy diet, desserts, festival recipes, meat and seafood recipes, etc.

【Contact us: [email protected]

Copyright © 2023